Inverse Psoriasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-02-24
Clinical Trial Update: Trial Twice Daily Application of LEO 124249 Ointment 30 mg/g in Treatment of Mild to Moderate Inverse Psoriasis [Phase 2]
A Phase 2 clinical trial evaluating twice-daily application of LEO 124249 ointment 30 mg/g for mild to moderate inverse psoriasis has comple…